Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aethlon Medical (AEMD)

Aethlon Medical (AEMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,170
  • Shares Outstanding, K 761
  • Annual Sales, $ 0 K
  • Annual Income, $ -13,390 K
  • EBIT $ -7 M
  • EBITDA $ -7 M
  • 60-Month Beta 1.64
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -2.01
  • Number of Estimates 1
  • High Estimate -2.01
  • Low Estimate -2.01
  • Prior Year -10.40
  • Growth Rate Est. (year over year) +80.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.83 unch
on 12/18/25
4.95 -42.83%
on 12/02/25
-1.37 (-32.62%)
since 11/18/25
3-Month
2.83 unch
on 12/18/25
8.27 -65.78%
on 10/03/25
-4.97 (-63.72%)
since 09/18/25
52-Week
2.83 unch
on 12/18/25
84.40 -96.65%
on 12/31/24
-50.02 (-94.65%)
since 12/18/24

Most Recent Stories

More News
Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million

SAN DIEGO , Dec. 5, 2025 /PRNewswire/ -- Aethlon Medical, Inc. ("Aethlon" or the "Company") (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening...

AEMD : 2.83 (-0.70%)
Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs

Results Support the Further Investigation of the Hemopurifier in Long COVID

AEMD : 2.83 (-0.70%)
Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

Clinical and research progress continues alongside substantial cost reductions.

AEMD : 2.83 (-0.70%)
Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

SAN DIEGO , Nov. 7, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases,...

AEMD : 2.83 (-0.70%)
Aethlon Medical Announces Reverse Stock Split

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Aethlon Medical...

AEMD : 2.83 (-0.70%)
Biotech and Medical Tech Stocks Report Breakthrough Clinical Trial Updates

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - October 8, 2025) - Investorideas.com, a go-to investing platform covering biotech and medtech stocks releases an industry snapshot looking...

AEMD : 2.83 (-0.70%)
Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial

SAN DIEGO , Oct. 7, 2025 /PRNewswire/ -- Aethlon Medical, Inc. ("Aethlon" or the "Company") (Nasdaq: AEMD) today provided observations on the preliminary changes in extracellular vesicle (EV), microRNA...

AEMD : 2.83 (-0.70%)
Aethlon Medical Announces Pricing of $4.5 Million Public Offering

SAN DIEGO , Sept. 4, 2025 /PRNewswire/ -- Aethlon Medical, Inc. ("Aethlon" or the "Company") (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer...

AEMD : 2.83 (-0.70%)
Innovation and IP in Medtech Stocks - How Patents Build Leaders

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - September 4, 2025) - Investorideas.com, a go-to investing platform covering biotech and medtech stocks releases an industry snapshot looking...

AEMD : 2.83 (-0.70%)
Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

SAN DIEGO , Sept. 3, 2025 /PRNewswire/ -- Aethlon Medical, Inc. ("Aethlon" or the "Company") (Nasdaq: AEMD) announced that U.S. Patent No. 12,409,260 (the "260 Patent") directed to treatment...

AEMD : 2.83 (-0.70%)

Business Summary

Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development...

See More

Key Turning Points

3rd Resistance Point 3.11
2nd Resistance Point 3.06
1st Resistance Point 2.94
Last Price 2.83
1st Support Level 2.77
2nd Support Level 2.72
3rd Support Level 2.60

See More

52-Week High 84.40
Fibonacci 61.8% 53.24
Fibonacci 50% 43.61
Fibonacci 38.2% 33.99
Last Price 2.83
52-Week Low 2.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar